Erin C McLaughlin

Structural Insights into the Design of Nonpeptidic Isothiazolidinone-containing Inhibitors of Protein-tyrosine Phosphatase 1B*

Richard Wynn, Mary Becker-Pasha, R. Wynn, 2006, Journal of Biological Chemistry.

Scholl Cyclizations of Aryl Naphthalenes: Rearrangement Precedes Cyclization.

Erin C McLaughlin, Richard P. Johnson, Aida Ajaz, 2015, The Journal of organic chemistry.

Phenyl shifts in substituted arenes via ipso arenium ions.

Erin C McLaughlin, Richard P. Johnson, Aida Ajaz, 2012, The Journal of organic chemistry.

CC chemokine receptor-3 (CCR3) antagonists: improving the selectivity of DPC168 by reducing central ring lipophilicity.

I. Kariv, K. Vaddi, M. Covington, 2007, Bioorganic & medicinal chemistry letters.

The road less traveled: New chemistry of old reactive intermediates

Erin C McLaughlin, 2012 .

Benzothiazole benzimidazole (S)-isothiazolidinone derivatives as protein tyrosine phosphatase-1B inhibitors.

R. Wynn, Wenyu Zhu, Phillip C. C. Liu, 2007, Bioorganic & medicinal chemistry letters.

Structure-based design and discovery of protein tyrosine phosphatase inhibitors incorporating novel isothiazolidinone heterocyclic phosphotyrosine mimetics.

Karl Blom, Michael Bower, James Pruitt, 2005, Journal of medicinal chemistry.

Potent benzimidazole sulfonamide protein tyrosine phosphatase 1B inhibitors containing the heterocyclic (S)-isothiazolidinone phosphotyrosine mimetic.

M. Bower, R. Wynn, Wenyu Zhu, 2006, Journal of medicinal chemistry.